These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Interpretation and inference in noninferiority randomized controlled trials in drug research.
    Author: Wangge G, Klungel OH, Roes KC, de Boer A, Hoes AW, Knol MJ.
    Journal: Clin Pharmacol Ther; 2010 Sep; 88(3):420-3. PubMed ID: 20668448.
    Abstract:
    Noninferiority (NI) trials in drug research are used for the purpose of demonstrating that a new treatment is not worse than a proven active comparator, thereby indirectly showing that the treatment is effective. This article explains and addresses the complications in the interpretation of NI trials that arise from the indirect comparison. On the basis of our review of 232 trials, we conclude that the interpretation and inference of NI trials are complicated, partly because of the incompleteness of the information.
    [Abstract] [Full Text] [Related] [New Search]